DARK SECRETS: 4 | Vintage Vibes

What to Expect From Gilead Sciences’ Q2 2025 Earnings Report

Gilead Sciences is expected to announce its fiscal second-quarter earnings next month, and analysts forecast a single-digit drop in its earnings.

Barchart · Jul 23, 2025

Millions will die in coming years if US funding for HIV programmes is not replaced, UN warns

US cuts could lead to four million AIDS-related deaths by 2029, according to UN officials.

Euronews · Jul 10, 2025

UN says if US funding for HIV programs is not replaced, millions more will die by 2029

A new U.N. AIDS agency report says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV

The Independent UK · Jul 10, 2025

US Approves Gilead's Twice-yearly Injection To Prevent HIV

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hailed as a major breakthrough in the fight against the sexually transmitted virus.

International Business Times · Jun 18, 2025

Here’s what to know about the twice-yearly preventative HIV shot

A twice-yearly drug called lenacapavir is now the longest-lasting type of PrEP

The Independent UK · Jun 18, 2025

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’

The Guardian - UK · Jun 17, 2025

Millions of doses of ‘pandemic-ending’ HIV jab at risk over Trump’s aid cuts

INTERVIEW: The funding for 2 million people to receive the twice-yearly preventative treatment lenacapavir is ‘receding in the chaos’ of the US president’s decision, the doctor behind the trial of the drug tells Rachel Schraer

The Independent UK · Jun 4, 2025

'The Handmaid's Tale's Ending Brought The Show Back To Its Worst Habits

The series finally ended, but not without going back to its most annoying trope.

Inverse · May 28, 2025

Unusual Options Alert: The Smart Money is Piling Into Gilead Sciences (GILD)

While the new political paradigm might not be the most conducive environment for Gilead Sciences, positive sentiment is brewing for GILD stock.

Barchart · May 19, 2025

Handmaid’s Tale star breaks down episode 1’s shock reunion

Emotional scene is part of how the show will end

The Independent UK · May 5, 2025